Mechanisms of transcriptional regulation of the human IL-3/GM-CSF locus by inducible tissue-specific promoters and enhancers

Critical Reviews in Immunology

Volumn 24, Issue 6, 2004, Pages 385-408

  Cockerill, Peter N ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chromatin; DNaseI hypersensitive sites; Enhancer; NFAT; T cells

Indexed keywords

CD28 ANTIGEN; CYTOKINE; DEOXYRIBONUCLEASE I; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN P50; T LYMPHOCYTE RECEPTOR; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA;

CELL TYPE; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENDOTHELIUM CELL; ENHANCER REGION; ENZYME ACTIVE SITE; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; GENETIC LINKAGE; GENOME; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; DEOXYRIBONUCLEASE I; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MICE; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 15444381278     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v24.i6.10     Document Type: Review

References (74)

1. Nicola NA. Hemopoietic cell growth factors and their receptors. Annu Rev Biochem 1989; 58:45-77.
2. Alexander WS. Cytokines in hematopoiesis. Int Rev Immunol 1998; 16(5-6):651-682.
3. Frazer KA, Ueda Y, Zhu Y, Gifford VR, Garofalo MR, Mohandas N, Martin CH, Palazzolo MJ, Cheng JF, Rubin EM. Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res 1997; 7(5): 495-512.
4. Loots GG, Locksley RM, Blankespoor CM, Wang ZE, Miller W, Rubin EM, Frazer KA. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000; 288(5463):136-140.
5. Russell NH. Autocrine growth factors and leukaemic haemopoiesis. Blood Rev 1992; 6(3):149-56.
6. Holyoake TL, Jiang X, Drummond MW, Eaves AC, Eaves CJ. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia 2002; 16(4):549-558.
7. Shannon MF, Coles LS, Vadas MA, Cockerill PN. Signals for activation of the GM-CSF promoter and enhancer in T cells. Crit Rev Immunol 1997; 17(3-4):301-323.
8. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15:707-747.
9. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003; 17(18):2205-2232.
10. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999; 285(5436):2129-2133.
11. Marienfeld R, Neumann M, Chuvpilo S, Escher C, Kneitz B, Avots A, Schimpl A, Serfling E. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur J Immunol 1997; 27(7):1601-1609.
12. Rincon M, Flavell RA. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J 1994; 13(18):4370-4381.
13. Johnson BV, Bert AG, Ryan GR, Condina A, Cockerill PN. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol Cell Biol 2004; 24(18):7914-7930.
14. Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci U S A 1993; 90(6):2466-2470.
15. Osborne CS, Vadas MA, Cockerill PN. Transcriptional regulation of mouse granulocyte-macrophage colony-stimulating factor/IL-3 locus. J Immunol 1995; 155(1):226-235.
16. Cockerill PN, Bert AG, Jenkins F, Ryan GR, Shannon MF, Vadas MA. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol Cell Biol 1995; 15(4):2071-209.
17. Cockerill GW, Bert AG, Ryan GR, Gamble JR, Vadas MA, Cockerill PN. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. Blood 1995; 86(7):2689-2698.
18. Duncliffe KN, Bert AG, Vadas MA, Cockerill PN. A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site. Immunity 1997; 6(2):175-185.
19. Cockerill PN, Bert AG, Roberts D, Vadas MA. The human granulocyte-macrophage colony-stimulating factor gene is autonomously regulated in vivo by an inducible tissue-specific enhancer. Proc Natl Acad Sci USA 1999; 96(26):15097-15102.
20. Bert AG, Burrows J, Hawwari A, Vadas MA, Cockerill PN. Reconstitution of T cell-specific transcription directed by composite NFAT/Oct elements. J Immunol 2000; 165(10):5646-5655.
21. Hawwari A, Burrows J, Vadas MA, Cockerill PN. The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J Immunol 2002; 169(4): 1876-1886.
22. Gross DS, Garrard WT. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 1988; 57:159-197.
23. Cockerill PN. Identification of DNaseI hypersensitive sites within nuclei. Methods Mol Biol 2000; 130:29-46.
24. Holloway AF, Rao S, Chen X, Shannon MF. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor κB proteins. J Exp Med 2003; 197(4):413-423.
25. Cakouros D, Cockerill PN, Bert AG, Mital R, Roberts DC, Shannon MF. A NF-κB/Sp1 region is essential for chromatin remodeling and correct transcription of a human granulocyte-macrophage colony-stimulating factor transgene. J Immunol 2001; 167(1):302-310.
26. Bert AG, Burrows J, Osborne CS, Cockerill PN. Generation of an improved luciferase reporter gene plasmid that employs a novel mechanism for high-copy replication. Plasmid 2000; 44(2):173-182.
27. Cockerill PN, Osborne CS, Bert AG, Grotto RJ. Regulation of GM-CSF gene transcription by core-binding factor. Cell Growth Differ 1996; 7(7):917-922.
28. Thirunavukkarasu K, Miles RR, Halladay DL, Onyia JE. Cryptic enhancer elements in luciferase reporter vectors respond to the osteoblast-spedfic transcription factor Osf2/Cbfa1. Biotechniques 2000; 28(3): 506-510.
29. Annicotte JS, Schoonjans K, Haby C, Auwerx J. An E-box in pGL3 reporter vectors precludes their use for the study of sterol regulatory element-binding proteins. Biotechniques 2001; 31(5):993-994, 996.
30. Giannakis G, Edmondson SR, Favaloro JM, Zajac JD, Greenland KJ. Aberrant cryptic responsiveness of the pCAT 3- and pGL3-promoter reporter vectors. Biotechniques 2003; 35(2):332-339.
31. Wilhelm BT, Landry JR, Takei F, Mager DL. Transcriptional control of murine CD94 gene: differential usage of dual promoters by lymphoid cell types. J Immunol 2003 Oct 15; 171(8):4219-4226.
32. Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene 1993; 8(12):3189-3197.
33. Chan JY, Slamon DJ, Nimer SD, Golde DW, Gasson JC. Regulation of expression of human granulocyte/ macrophage colony-stimulating factor. Proc Natl Acad Sci U S A 1986; 83(22):8669-8673.
34. Miyatake S, Otsuka T, Yokota T, Lee F, Arai K. Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: Comparison of the mouse and human genes. EMBO J 1985; 4(10): 2561-2568.
35. Stanley E, Metcalf D, Sobieszczuk P, Gough NM, Dunn AR. The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: Evidence for utilisation of alternative promoters. EMBO J 1985; 4(10):2569-2573.
36. Jenkins F, Cockerill PN, Bohmann D, Shannon MF. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells. J Immunol 1995; 155(3): 1240-1251.
37. Tsuboi A, Muramatsu M, Tsutsumi A, Arai K, Arai N. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells. Biochem Biophys Res Commun 1994; 199(2):1064-1072.
38. Tsuboi A, Masuda ES, Naito Y, Tokumitsu H, Arai K, Arai N. Calcineurin potentiates activation of the granulocyte-macrophage colony-stimulating factor gene in T cells: involvement of the conserved lymphokine element O. Mol Biol Cell 1994; 5(1):119-128.
39. McCafrrey PG, Jain J, Jamieson C, Sen R, Rao A. A T cell nuclear factor resembling NF-AT binds to an NF-kappa B site and to the conserved lymphokine promoter sequence "cytokine-1." J Biol Chem 1992; 267(3):1864-1871.
40. Myatake S, Shlomai J, Arai K, Arai N. Characterization of the mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) gene promoter: nuclear factors that interact with an element shared by three lymphokine genes-those for GM-CSF, interleukin-4 (IL-4), and IL-5. Mol Cell Biol 1991; 11(12): 5894-5901.
41. Thomas RS, Tymms MJ, McKinlay LH, Shannon MF, Seth A, Kola I. ETS, NFκB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 1997; 14(23):2845-2855.
42. Masuda ES, Tokumitsu H, Tsuboi A, Shlomai J, Hung P, Aral K, Arai N. The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLEO mediates induction signals in T cells and is recognized by factors related to AP1 and NFAT. Mol Cell Biol 1993; 13(12):7399-7407.
43. Wasylyk B, Wasylyk C, Flores P, Begue A, Leprince D, Stehelin D. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 1990; 346 (6280):191-193.
44. Salerno MS, Schwenger GT, Sanderson CJ, Mordvinov VA. Binding of octamer factors to the murine IL-5 CLEO in primary T-cells and a T-cell line. Cytokine 2001; 15(1):4-9.
45. Kaushansky K, Shoemaker SG, O'Rork CA, McCarty JM. Coordinate regulation of multiple human lymphokine genes by Oct-1 and potentially novel 45 and 43 kDa polypeptides. J Immunol 1994; 152(4):1812-1820.
46. Shoemaker SG, Hromas R, Kaushansky K. Transcriptional regulation of interleukin 3 gene expression in T lymphocytes. Proc Natl Acad Sci U S A 1990; 87(24): 9650-9654.
47. Mathey-Prevot B, Andrews NC, Murphy HS, Kreissman SG, Nathan DG. Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A 1990; 87(13):5046-5050.
48. Davies K,TePas EC, Nathan DG, Mathey-Prevot B. Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. Blood 1993; 81(4):928-934.
49. Park JH, Kaushansky K, Levitt L. Transcriptional regulation of interleukin 3 (IL3) in primary human T lymphocytes: Role of AP-1- and octamer-binding proteins in control of IL3 gene expression. J Biol Chem 1993; 268(9):6299-6308.
50. Ullman KS, Northrop JP, Admon A, Crabtree GR. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes. Genes Dev 1993; 7(2): 188-196.
51. Pfeuffer I, Klein-Hessling S, Heinfling A, Chuvpilo S, Escher C, Brabletz T, Hentsch B, Schwarzenbach H, Matthias P, Serfling E. Octamer factors exert a dual effect on die IL-2 and IL-4 promoters. J Immunol 1994; 153(12):5572-5585.
52. Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 1995; 11(12):2667-2674.
53. Tsuboi A, Sugimoto K, Yodoi J, Miyatake S, Arai K, Arai N. A nuclear factor NF-GM2 that interacts with a regulatory region of the GM-CSF gene essential for its induction in responses to T-cell activation: purification from human T-cell leukemia line Jurkat cells and similarity to NF-kappa B. Int Immunol 1991; 3(8):807-817.
54. Miyatake S, Seiki M, Yoshida M, Arai K. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol Cell Biol 1988; 8(12):5581-5587.
55. Himes SR, Katsikeros R, Shannon MF. Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax. J Virol 1996; 70(6):4001-4008.
56. Masuda ES, Yamaguchi-Iwai Y, Tsuboi A, Hung P, Arai K, Arai N. The transcription factor Sp1 is required for induction of the murine GM-CSF promoter in T cells. Biochem Biophys Res Commun 1994; 205(3):1518-1525.
57. Kochetkova M, Iversen PO, Lopez AF, Shannon MF. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells. J Clin Invest 1997; 99(12):3000-3008.
58. Shannon MF, Gamble JR, Vadas MA. Nuclear proteins interacting with the promoter region of the human granulocyte/macrophage colony-stimulating factor gene. Proc Natl Acad Sci U S A 1988; 85(3):674-678.
59. Himes SR, Coles LS, Reeves R, Shannon MF. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity 1996; 5(5):479-489.
60. Fraser JD, Weiss A. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol Cell Biol 1992; 12(10):4357-4363.
61. Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck JY, Grumont RJ. Rel-defident T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A 1996; 93(8):3405-3409.
62. Shang C, Attema J, Cakouros D, Cockerill PN, Shannon MF. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter. Int Immunol 1999; 11(12):1945-1956.
63. Woodcock CL, Frado LL, Rattner JB. The higher-order structure of chromatin: Evidence for a helical ribbon arrangement. J Cell Biol 1984; 99(1 Pt 1):42-52.
64. Wolin M, Kornuc M, Hong C, Shin SK, Lee F, Lau R, Nimer S. Differential effect of HTLV infection and HTLV Tax on interleukin 3 expression. Oncogene 1993; 8(7):1905-1911.
65. Ryan GR, Vadas MA, Shannon MF. T-cell functional regions of the human IL-3 proximal promoter. Mol Reprod Dev 1994; 39(2):200-207.
66. Zhang W, Zhang J, Kornuc M, Kwan K, Frank R, Nimer SD. Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter. Mol Cell Biol 1995; 15(11):6055-6063.
67. Cameron S, Taylor DS, TePas EC, Speck NA, Mathey-Prevot B. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood 1994; 83(10):2851-2859.
68. Taylor DS, Laubach JP, Nathan DG, Mathey-Prevot B. Cooperation between core binding factor and adjacent promoter elements contributes to the tissue-specific expression of interleukin-3. J Biol Chem 1996; 271 (24):14020-14027.
69. Uchida H, Zhang J, Nimer SD. AML1A and AML1B can transactivate the human IL-3 promoter. J Immunol 1997; 158(5):2251-2258.
70. Koyano-Nakagawa N, Nishida J, Baldwin D, Arai K, Yokota T. Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter. Mol Cell Biol 1994; 14(8): 5099-5107.
71. Gottschalk LR, Giannola DM, Emerson SG. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites. J Exp Med 1993; 178(5): 1681-1692.
72. Engeland K, Andrews NC, Mathey-Prevot B. Multiple proteins interact with the nuclear inhibitory protein represser element in the human interleukin-3 promoter. J Biol Chem 1995; 270(41):24572-12579.
73. Kelso A, Gough NM. Coexpression of granulocyte-macrophage colony-stimulating factor, gamma interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones. Proc Natl Acad Sci USA 1988; 85(23):9189-9193.
74. Gribnau J, de Boer E, Trimborn T, Wijgerde M, Milot E, Grosveld F, Fraser P. Chromatin interaction mechanism of transcriptional control in vivo. EMBO J 1998; 17(20):6020-6027.